...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and antibacterial profiles of targeted triclosan derivatives
【24h】

Synthesis and antibacterial profiles of targeted triclosan derivatives

机译:靶向三氯烷衍生物的合成和抗菌谱

获取原文
获取原文并翻译 | 示例

摘要

There is an ongoing urgent need for new targeted antibacterial compounds with novel mechanisms of action for the treatment of infections caused by bacteria that are resistant to currently available materials. Since the expression of glycosidase enzymes within bacteria is unequally distributed, glycoside derivatives of antibacterial agents offer potential as targeted prodrugs for bacterial infections. Herein we report the synthesis and characterisation of four alpha-D-glycopyranosides and three beta-D-glycopyranosides of the broad antibacterial agent triclosan, in generally good synthetic yields, and with excellent purities. Each glycoside was analysed to determine its ability to inhibit the growth of a wide range of Gram-negative and Gram-positive organisms, including many of clinical significance. All of the triclosan glycosides that were synthesized demonstrated antibacterial activity against many of the organisms that were examined. For example, fi-galactoside (3a) and alpha-arabinoside (3c) had MIC values of 0.5 mu g/ml for several strains of S. aureus and S. haemolyticus. The triclosan glycosides were also generally found to be more water soluble and much more selective than the underivatized triclosan, making them ideal both for the targeted inhibition of bacterial growth and as agents for the selective recovery of bacteria from mixed cultures. In the latter case, two Bacillus strains could be identified from various strains of Bacillus and Staphylococcus after inoculation onto Nutrient Agar No. 2 with 0.25 mu g/ml triclosan-alpha-D-glucopyranoside (3e). This glucoside may, therefore, be of use for the isolation and identification of the food-poisoning organism Bacillus cereus. (C) 2018 Elsevier Masson SAS. All rights reserved.
机译:具有新的靶向抗菌化合物的新型抗菌化合物,具有新的作用机制,用于治疗对目前可用材料的细菌造成的细菌引起的感染。由于细菌内的糖苷酶酶的表达是不均分布的,因此抗菌剂的糖苷衍生物为细菌感染提供潜在的靶向前药。在此,我们报告了宽抗菌剂三氯丙烷三种α-D-甘吡喃糖苷和三种β-D-甘油酯的合成和表征,通常是良好的合成产率和优异的纯度。分析了每种糖苷,以确定其抑制各种革兰氏阴性和革兰氏阳性生物体的生长的能力,包括许多临床意义。合成的所有三胞苷糖苷都证明了针对检查的许多生物体的抗菌活性。例如,Fi-半乳糖酰亚胺(3A)和α-阿拉伯核苷(3C)的MIC值为0.5μg/ ml,用于几种菌株和血溶液的几种菌株。三氯烷糖苷也通常发现溶于水溶于和比未生病的三氯烷更易溶,更为理想,使其成为针对细菌生长的靶向抑制和作为来自混合培养物的细菌的选择性恢复的药剂。在后一种情况下,在用0.25μg/ ml三胰岛素-D-吡喃吡喃(3E)接种到营养琼脂No.2上,可以从各种杆菌和葡萄球菌中鉴定两个杆菌菌株。因此,这种葡萄糖苷可以用于分离和鉴定食物中毒生物芽孢杆菌。 (c)2018年Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号